Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Commentary on "care of the adult patient with down syndrome".

Shulman LP.

South Med J. 2014 Nov;107(11):722-3. doi: 10.14423/SMJ.0000000000000194. No abstract available.

PMID:
25365442
2.

Postpartum glucose tolerance in women with gestational diabetes using levonorgestrel intrauterine contraception.

Kiley JW, Hammond C, Niznik C, Rademaker A, Liu D, Shulman LP.

Contraception. 2015 Jan;91(1):67-70. doi: 10.1016/j.contraception.2014.08.004. Epub 2014 Aug 12.

PMID:
25193535
3.

Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops.

van Breemen RB, Yuan Y, Banuvar S, Shulman LP, Qiu X, Alvarenga RF, Chen SN, Dietz BM, Bolton JL, Pauli GF, Krause E, Viana M, Nikolic D.

Mol Nutr Food Res. 2014 Oct;58(10):1962-9. doi: 10.1002/mnfr.201400245. Epub 2014 Sep 16.

PMID:
25045111
4.

The best prophet of the future is the past: oral contraception and novel components.

Shulman LP.

J Womens Health (Larchmt). 2014 Mar;23(3):195-6. doi: 10.1089/jwh.2014.4733. Epub 2014 Feb 14. No abstract available.

PMID:
24528194
5.

Has the pendulum begun to swing back?

Shulman LP.

Menopause. 2014 Mar;21(3):211-2. doi: 10.1097/GME.0000000000000212. No abstract available.

PMID:
24496090
6.

Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.

Walega DR, Rubin LH, Banuvar S, Shulman LP, Maki PM.

Menopause. 2014 Aug;21(8):807-14. doi: 10.1097/GME.0000000000000194.

PMID:
24496086
7.

Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen.

Shulman LP.

J Fam Plann Reprod Health Care. 2013 Jul;39(3):211-6. doi: 10.1136/jfprhc-2013-100605. Epub 2013 May 24. Review.

PMID:
23709606
8.

Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms.

Drogos LL, Rubin LH, Geller SE, Banuvar S, Shulman LP, Maki PM.

Menopause. 2013 Dec;20(12):1236-42. doi: 10.1097/GME.0b013e318291f5a6.

9.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.

Bitzer J, Amy JJ, Beerthuizen R, Birkhäuser M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C.

J Fam Plann Reprod Health Care. 2013 Jul;39(3):156-9. doi: 10.1136/jfprhc-2013-100624. Epub 2013 Apr 12. No abstract available.

PMID:
23585363
10.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.

Bitzer J, Amy JJ, Beerthuizen R, Birkhäuser M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C.

Eur J Contracept Reprod Health Care. 2013 Jun;18(3):143-7. doi: 10.3109/13625187.2013.792637. Epub 2013 Apr 12. No abstract available.

PMID:
23578274
11.

The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer.

Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP.

PLoS One. 2012;7(5):e37891. doi: 10.1371/journal.pone.0037891. Epub 2012 May 25.

12.

In the nick of time: Despite 2 treatments a cervical ectopic pregnancy continued to advance.

Miller ES, Marko K, Cohen L, Dungan JS, Shulman LP.

Am J Obstet Gynecol. 2012 May;206(5):450.e1-2. doi: 10.1016/j.ajog.2012.01.027. Epub 2012 Jan 28. No abstract available.

PMID:
22342896
13.
14.

The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.

Shulman LP.

Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057. Review.

PMID:
21961825
15.

Estradiol valerate and dienogest: a new approach to oral contraception.

Kiley JW, Shulman LP.

Int J Womens Health. 2011;3:281-6. doi: 10.2147/IJWH.S22645. Epub 2011 Aug 18.

16.

Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen.

Marr J, Niknian M, Shulman LP, Lynen R.

Contraception. 2011 Jul;84(1):81-6. doi: 10.1016/j.contraception.2010.10.010. Epub 2010 Dec 17.

PMID:
21664515
17.

One small step and one giant leap for noninvasive prenatal screening: an editorial.

Shulman LP.

Am J Obstet Gynecol. 2011 Mar;204(3):183-5. doi: 10.1016/j.ajog.2011.01.042. No abstract available.

PMID:
21376157
18.

3-D ultrasound of the fetal ear and fetal autosomal trisomies: a pilot study of a new screening protocol.

Ginsberg NA, Cohen L, Dungan JS, Concialdi S, Mangers K, Shulman LP.

Prenat Diagn. 2011 Mar;31(3):311-4. doi: 10.1002/pd.2701. Epub 2011 Feb 4.

PMID:
21294134
19.

50 years of "The Pill": celebrating a golden anniversary.

Szarewski A, Mansour D, Shulman LP.

J Fam Plann Reprod Health Care. 2010 Oct;36(4):231-8. doi: 10.1783/147118910793048665.

20.

Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC center for botanical dietary supplements research study of black cohosh and red clover.

Shulman LP, Banuvar S, Fong HH, Farnsworth NR.

Fitoterapia. 2011 Jan;82(1):88-91. doi: 10.1016/j.fitote.2010.10.013. Epub 2010 Oct 27. Review.

PMID:
21034798
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk